Evidence map›Paper›PMID 42646479›Full record

ArticleMarine drugs2026

Two New Indole Derivatives from the Beibu Gulf Coral-Derived Fungus

Hui Shi, Guihua Yang, Xiaolin Liu, Miaoping Lin, Humu Lu, Chenghai Gao, Yonghong Liu, Xiaowei Luo

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui ShiGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Guihua YangGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Xiaolin LiuGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Miaoping LinGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Humu LuGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Chenghai GaoGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-7524-8049
Yonghong LiuGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0001-8327-3108
Xiaowei LuoGuangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-Efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Technology Innovation Center for the Development and Utilization of Marine Drugs and Bioproducts for Beibu Gulf, Ministry of Natural Resources, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-2114-1609

Funding

Guangxi Science and Technology Department 2024GXNSFFA010004、LT2600640033Guangxi University of Chinese Medicine No.202407, YCSW2025457
6 · The paper itself

Abstract

Two new indole derivatives (

Indexed as

AnthozoaAnti-Bacterial AgentsIndolesPestalotiopsisAnimalsAnti-Inflammatory AgentsBacillus subtilisMicrobial Sensitivity TestsNF-kappa BStaphylococcus aureusStaphylococcus epidermidisAnti-Bacterial AgentsAnti-Inflammatory AgentsIndolesNF-kappa Bbioactivityindole derivativesmarine fungusPestalotiopsis microspora

Identifiers

PMID42646479
PMCPMC13514921

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.